NYSE
9.32USD
-0.04 (-0.43%)
We have scored 15 news catalysts on Haleon plc (HLN) over the past 12 months. The biggest single-day move next to one of them came Mar 20, 2026, when HLN closed −1.6%: “Día Mundial de la Salud Bucodental 2026: la FDI insta a los gobiernos a convertir en acciones los compromisos de la ONU”. Coverage across the window leans positive (average ticker sentiment +0.27). Most of the impact sits in sector healthcare and short squeeze potential.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
40.8B
P/E
—
EPS
—
Beta
0.24
52W range
8.65-11.28
Day range
9.29–9.39
Open
9.35
Prev close
9.36
Volume
7.3M
Avg volume
11M
Dividend
0.12
IPO
2022-07-25
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Haleon plc — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for HLN: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
